Form 483

Lupin Limited Form 483, 2015-07-17

FDA issued a Form 483 to Lupin Limited on 2015-07-17 with 18 public-safe observations.

483· Form 483 issuedHuman Drugs18 observations

Lupin Limited · Verna, India · Issued July 17, 2015

Overview

  • 18 public-safe observations are available for this inspection.
  • 9 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

17 Jul 2015
21 CFR 211.110(a)

Control procedures to monitor and validate performance

Cited by Charanjeet Jassal, Luis A Dasta

17 Jul 2015
21 CFR 211.165(f)

Failing drug products not rejected

Cited by Charanjeet Jassal, Luis A Dasta

17 Jul 2015
21 CFR 211.170(b)

Annual visual exams of drug products

Cited by Charanjeet Jassal, Luis A Dasta

17 Jul 2015
21 CFR 211.192

Investigations of discrepancies, failures

Cited by Charanjeet Jassal, Luis A Dasta

17 Jul 2015
21 CFR 211.42(c)

Defined areas of adequate size for operations

Cited by Charanjeet Jassal, Luis A Dasta

Inspected site

LLLupin LimitedVerna, India

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.110(a)Cited across public-safe Form 483 observations2x
21 CFR 211.165(f)Cited across public-safe Form 483 observations2x
21 CFR 211.170(b)Cited across public-safe Form 483 observations2x
21 CFR 211.192Cited across public-safe Form 483 observations2x
21 CFR 211.42(c)Cited across public-safe Form 483 observations2x
21 CFR 211.67(b)Cited across public-safe Form 483 observations2x
21 CFR 211.67(c)Cited across public-safe Form 483 observations2x
21 CFR 211.68(b)Cited across public-safe Form 483 observations2x
21 CFR 211.80(a)Cited across public-safe Form 483 observations2x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 18 observations

The source PDF and every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere